Milnacipran Hydrochloride Tablet, Film Coated
Product Images NDC 68462-765

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Milnacipran Hydrochloride (NDC 68462-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Glenmark Pharmaceuticals Inc., Usa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

FDA Label Image

Figure2 (Figure2)

FDA Label Image

Glenmarklogo1 (Glenmarklogo1)

"Glenmark" is a pharmaceutical company that produces a variety of medications and healthcare products. They are known for their focus on research and development to create innovative healthcare solutions.*

FDA Label Image

Glenmarklogo2 (Glenmarklogo2)

FDA Label Image

Label100mg (Label100mg)

FDA Label Image

Label12-5mg (Label12 5mg)

FDA Label Image

Label25mg (Label25mg)

This is information about Milnacipran HCL tablets, each containing 25 mg of the active ingredient. The text provides guidance on dosage, storage conditions (between 15°C and 30°C), contact information for questions, and the need to keep the medication out of reach of children. It also mentions the requirement to dispense the medication guide to each patient. User support contact is provided via a phone number and a website link. Additionally, it states the distributor as Glenmark Pharmaceuticals Inc., USA.*

FDA Label Image

Label50mg (Label50mg)

FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.